Literature DB >> 8131203

IFN-gamma stimulates IgG2 production from bovine B cells costimulated with anti-mu and mitogen.

D M Estes1, N M Closser, G K Allen.   

Abstract

The effect of interferon-gamma (IFN-gamma) antibody production by anti-mu- or pokeweed mitogen-stimulated bovine B cells was studied. IFN-gamma induced IgG2 secretion in isolated bulk B cell populations and in B cells sorted for IgM expression. IgM production was suppressed by the presence of IFN-gamma alone but this effect was antagonized by interleukin 2 (IL2). The effects of IFN-gamma on secreted levels of IgM, IgG1, and IgG2 correlated with the frequencies of cells expressing transcripts of the respective isotypes when stimulated with IFN-gamma-containing T cell supernatants. These results indicate that IFN-gamma plays a key role in IgG2 production in the bovine by directly affecting suitably stimulated B cells. The ability of IL2 to synergize with IFN-gamma to augment both the IgM and IgG2 responses implicates a TH1-like subset in regulation of this isotype.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8131203     DOI: 10.1006/cimm.1994.1078

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  32 in total

1.  Cloning, expression and biological function of the bovine CD40 homologue: role in B-lymphocyte growth and differentiation in cattle.

Authors:  A Hirano; W C Brown; D M Estes
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

2.  Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and interleukin-2 for protection against bovine tuberculosis.

Authors:  D N Wedlock; B Vesosky; M A Skinner; G W de Lisle; I M Orme; B M Buddle
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  Bovine CD4(+) T-lymphocyte clones specific for rhoptry-associated protein 1 of Babesia bigemina stimulate enhanced immunoglobulin G1 (IgG1) and IgG2 synthesis.

Authors:  W C Brown; T F McElwain; G H Palmer; S E Chantler; D M Estes
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

4.  Effects of type I/type II interferons and transforming growth factor-beta on B-cell differentiation and proliferation. Definition of costimulation and cytokine requirements for immunoglobulin synthesis and expression.

Authors:  D M Estes; W Tuo; W C Brown; J Goin
Journal:  Immunology       Date:  1998-12       Impact factor: 7.397

5.  Identification of novel antigenic proteins in a complex Anaplasma marginale outer membrane immunogen by mass spectrometry and genomic mapping.

Authors:  Job E Lopez; William F Siems; Guy H Palmer; Kelly A Brayton; Travis C McGuire; Junzo Norimine; Wendy C Brown
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

6.  Immune responses against rHaa86 in cross-bred cattle.

Authors:  Binod Kumar; D D Ray; Srikant Ghosh
Journal:  J Parasit Dis       Date:  2013-07-10

7.  CD4(+) T lymphocytes from calves immunized with Anaplasma marginale major surface protein 1 (MSP1), a heteromeric complex of MSP1a and MSP1b, preferentially recognize the MSP1a carboxyl terminus that is conserved among strains.

Authors:  W C Brown; G H Palmer; H A Lewin; T C McGuire
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

8.  Stimulation of nitric oxide production in macrophages by Babesia bovis.

Authors:  R W Stich; L K Shoda; M Dreewes; B Adler; T W Jungi; W C Brown
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

9.  Evolution of ADAMTS13 antibodies in a fatal case of thrombotic thrombocytopenic purpura.

Authors:  Lingli Dong; Visalam Chandrasekaran; Wenhua Zhou; Han-Mou Tsai
Journal:  Am J Hematol       Date:  2008-10       Impact factor: 10.047

10.  Role of alpha/beta interferons in the attenuation and immunogenicity of recombinant bovine respiratory syncytial viruses lacking NS proteins.

Authors:  Jean-Francois Valarcher; Julie Furze; Sara Wyld; Roy Cook; Karl-Klaus Conzelmann; Geraldine Taylor
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.